It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2007.
2007 | Kolkata, West Bengal, India | Struck OffSigcap Pharmaceuticals (I) Private Limited, a struck off private limited company, was established on 25 October 2007 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232WB2007PTC120042. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.88 M.
It upholds a compliant status. Its leadership includes Rahul Todi (Director), Seema Jain (Director). Past directors included Anshuman Sarkar, Bandana Rakhit, Seema Jain. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 686, Anandapur, 7Th Floor, E.M. Bypass, R.B. Connector Junction,, Kolkata, West Bengal, 700107.
U24232WB2007PTC120042
120042
25 October 2007
₹1.00 Cr
₹7.88 M
Roc Kolkata
Unlisted
Struck Off
Explore comprehensive insights into Sigcap Pharmaceuticals (I) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Todi | Director | 25 Oct 2007 | Current |
| Seema Jain | Director | 30 Aug 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Aug 2022 | Past |
| Pramod Abcsdd | Director | 10 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2008 | Past |
| Pramod Abcsdd | Director | 01 Jan 2009 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sigcap Pharmaceuticals (I) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.07% increase. The company also saw a substantial fall in profitability, with a 264.78% decrease in profit. The company's net worth dipped by a decrease of 3.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Sigcap Pharmaceuticals (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sigcap Pharmaceuticals (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sigcap Pharmaceuticals (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sigcap Pharmaceuticals (I)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sigcap Pharmaceuticals (I) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Progress on Sigcap Pharmaceuticals (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata. was documented.
The activity Seema Jain was appointed as a Director was appointed as a Director on 30 Aug 2022 & has been associated with this company since 3 years 3 months . was completed.
Progress on Rahul Todi was appointed as a Director was appointed as a Director on 25 Oct 2007 & has been associated with this company since 18 years 1 month . was documented.
Sigcap Pharmaceuticals (I) Private Limited was registered on 25 Oct 2007 with Roc Kolkata & aged 18 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Sigcap Pharmaceuticals (I) Private Limited is U24232WB2007PTC120042.
Sigcap Pharmaceuticals (I) Private Limited is headquartered at 686, Anandapur, 7Th Floor, E.M. Bypass, R.B. Connector Junction,, Kolkata, West Bengal, 700107.
Sigcap Pharmaceuticals (I) Private Limited was incorporated on 25 October 2007.
The current directors of Sigcap Pharmaceuticals (I) Private Limited are
The primary industry of Sigcap Pharmaceuticals (I) Private Limited is Pharma.
Sigcap Pharmaceuticals (I) Private Limited is unlisted.
The authorized capital of Sigcap Pharmaceuticals (I) Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.88 M.
The compliance status of Sigcap Pharmaceuticals (I) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX